Abolis provides tailor-made industrial solutions based on micro-organisms for a wide range of industries –– from food and healthcare to cosmetics and chemistry. With a strong focus on sustainability, Abolis helps industries transition to greener models by implementing biodegradable products, enhancing supply chain resilience, reducing greenhouse gas emissions, and promoting environmental safety. Their innovative solutions also enable the use of sustainable raw materials, especially in healthcare, driving progress across multiple sectors.
Specialty and fine chemicals industries, in particular, face challenges such as increasing the bio-based content of their products, minimizing environmental impact, and reducing GHG emissions—all while maintaining product quality and consistent supply chains. To stay competitive, these firms must continuously invest in R&D, foster innovation, and build strong relationships with customers and suppliers.
Biotechnology offers transformative opportunities for producing fine chemicals by enabling more efficient, sustainable manufacturing processes like fermentation and enzymatic catalysis. Abolis taps into the untapped potential of microorganisms to develop innovative bioproduction solutions, including small molecules, proteins, and microbial cultures. These solutions provide eco-friendly and cost-effective alternatives to petrochemical-based products and plant extracts, advancing a more sustainable and resilient industrial future.
